tag:blogger.com,1999:blog-3727160219530426882008-07-13T14:24:27.988-07:00Oncology BiomarkersThis website is dedicated to Oncology Biomarker discussion.DNAmitenoreply@blogger.comBlogger3125tag:blogger.com,1999:blog-372716021953042688.post-9533654444119545152008-06-15T17:24:00.000-07:002008-07-13T14:24:28.124-07:00Colby Pharmaceutical Company to treat metastatic prostate cancer after the prostate is removedOne of the most unhappy groups of men is a group with a prostate cancer biomarker(PSA) in peripheral blood after their prostate has been removed. If the disease is metastasized in the bone, the prognosis for these men is very poor.<br /><br />However, Colby Pharmaceutical Company (www.colbypharma.com), is working on bringing highly potent oxidative stress modulating drugs to market that show efficacy in pre-clinical trials. <br /><br />What is PSA:<br />Prostate specific antigen (PSA) is a protein produced by the cells of the prostate gland. PSA is present in small quantities in the serum of normal men, and is often elevated in the presence of prostate cancer and in other prostate disorders. A blood test to measure PSA is the most effective test currently available for the early detection of prostate cancer. Rising levels of PSA over time are associated with both localized and metastatic prostate cancer (CaP).<br /><br /><script type="text/javascript"><br />var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");<br />document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));<br /></script><br /><script type="text/javascript"><br />var pageTracker = _gat._getTracker("UA-1017239-5");<br />pageTracker._initData();<br />pageTracker._trackPageview();<br /></script>DNAmitenoreply@blogger.comtag:blogger.com,1999:blog-372716021953042688.post-90780520134769124842008-01-29T13:11:00.000-08:002008-01-29T13:34:54.864-08:00Upcoming Prostate Cancer DiagnosticsOne interesting startup company I came across is Aureon, which developed a biomarker diagnostic, which predicts PSA recurrence and clinical disease progression in patients who have undergone radical prostatectomy. Samples are collected using needle biopsy.<br /><br />The first diagnostic is Prostate Px, which looks at a set of seven protein prostate cancer biomarkers to fairly accurately predict PSA recurrence.<br /><br />Among Aureon's founders are leading scientists at Memorial Sloan-Kettering Cancer Center, Yale Cancer Center, and Albert Einstein College of Medicine. he company is well financed and is rapidly moving ahead with its proastata diagnostic.<br /><br />ww.aureon.comDNAmitenoreply@blogger.comtag:blogger.com,1999:blog-372716021953042688.post-29559702028731771222008-01-18T20:05:00.000-08:002008-01-18T20:14:35.557-08:00Oncology Biomarkers Meeting CompleteI attended <a href="http://www.gtcbio.com">GTCbio's</a> Oncology Biomarkers conference held in San Francisco's hotel Whitcomb last week. The <a href="http://www.biotechnologymeetings.com">biotech calendar </a>has many biomarker conferences this year, but this event was definitely one of the best out there.<br /><br />The level of delegates was striking and presentations were top notch!DNAmitenoreply@blogger.com